Kaustubh Supekar1, Carlo de Los Angeles1, Srikanth Ryali1, Kaidi Cao2, Tengyu Ma2, Vinod Menon3. 1. Department of Psychiatry & Behavioral Sciences, Stanford University, USA. 2. Department of Computer Science, Stanford University, USA. 3. Department of Psychiatry & Behavioral Sciences, Stanford University, USA; Department of Neurology & Neurological Sciences, Stanford University, USA and Wu Tsai Neurosciences Institute, Stanford University, USA.
Abstract
BACKGROUND: Autism spectrum disorder (ASD) is a highly heterogeneous disorder that affects nearly 1 in 189 females and 1 in 42 males. However, the neurobiological basis of gender differences in ASD is poorly understood, as most studies have neglected females and used methods ill-suited to capture such differences. AIMS: To identify robust functional brain organisation markers that distinguish between females and males with ASD and predict symptom severity. METHOD: We leveraged multiple neuroimaging cohorts (ASD n = 773) and developed a novel spatiotemporal deep neural network (stDNN), which uses spatiotemporal convolution on functional magnetic resonance imaging data to distinguish between groups. RESULTS: stDNN achieved consistently high classification accuracy in distinguishing between females and males with ASD. Notably, stDNN trained to distinguish between females and males with ASD could not distinguish between neurotypical females and males, suggesting that there are gender differences in the functional brain organisation in ASD that differ from normative gender differences. Brain features associated with motor, language and visuospatial attentional systems reliably distinguished between females and males with ASD. Crucially, these results were observed in a large multisite cohort and replicated in a fully independent cohort. Furthermore, brain features associated with the motor network's primary motor cortex node predicted the severity of restricted/repetitive behaviours in females but not in males with ASD. CONCLUSIONS: Our replicable findings reveal that the brains of females and males with ASD are functionally organised differently, contributing to their clinical symptoms in distinct ways. They inform the development of gender-specific diagnoses and treatment strategies for ASD, and ultimately advance precision psychiatry.
BACKGROUND: Autism spectrum disorder (ASD) is a highly heterogeneous disorder that affects nearly 1 in 189 females and 1 in 42 males. However, the neurobiological basis of gender differences in ASD is poorly understood, as most studies have neglected females and used methods ill-suited to capture such differences. AIMS: To identify robust functional brain organisation markers that distinguish between females and males with ASD and predict symptom severity. METHOD: We leveraged multiple neuroimaging cohorts (ASD n = 773) and developed a novel spatiotemporal deep neural network (stDNN), which uses spatiotemporal convolution on functional magnetic resonance imaging data to distinguish between groups. RESULTS: stDNN achieved consistently high classification accuracy in distinguishing between females and males with ASD. Notably, stDNN trained to distinguish between females and males with ASD could not distinguish between neurotypical females and males, suggesting that there are gender differences in the functional brain organisation in ASD that differ from normative gender differences. Brain features associated with motor, language and visuospatial attentional systems reliably distinguished between females and males with ASD. Crucially, these results were observed in a large multisite cohort and replicated in a fully independent cohort. Furthermore, brain features associated with the motor network's primary motor cortex node predicted the severity of restricted/repetitive behaviours in females but not in males with ASD. CONCLUSIONS: Our replicable findings reveal that the brains of females and males with ASD are functionally organised differently, contributing to their clinical symptoms in distinct ways. They inform the development of gender-specific diagnoses and treatment strategies for ASD, and ultimately advance precision psychiatry.
Authors: Christopher Hammill; Jason P Lerch; Margot J Taylor; Stephanie H Ameis; M Mallar Chakravarty; Peter Szatmari; Evdokia Anagnostou; Meng-Chuan Lai Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2021-03-10
Authors: A Di Martino; C-G Yan; Q Li; E Denio; F X Castellanos; K Alaerts; J S Anderson; M Assaf; S Y Bookheimer; M Dapretto; B Deen; S Delmonte; I Dinstein; B Ertl-Wagner; D A Fair; L Gallagher; D P Kennedy; C L Keown; C Keysers; J E Lainhart; C Lord; B Luna; V Menon; N J Minshew; C S Monk; S Mueller; R-A Müller; M B Nebel; J T Nigg; K O'Hearn; K A Pelphrey; S J Peltier; J D Rudie; S Sunaert; M Thioux; J M Tyszka; L Q Uddin; J S Verhoeven; N Wenderoth; J L Wiggins; S H Mostofsky; M P Milham Journal: Mol Psychiatry Date: 2013-06-18 Impact factor: 15.992
Authors: Antonio Napolitano; Sara Schiavi; Piergiorgio La Rosa; Maria Camilla Rossi-Espagnet; Sara Petrillo; Francesca Bottino; Emanuela Tagliente; Daniela Longo; Elisabetta Lupi; Laura Casula; Giovanni Valeri; Fiorella Piemonte; Viviana Trezza; Stefano Vicari Journal: Front Psychiatry Date: 2022-05-13 Impact factor: 5.435